I think the deals signed to date demonstrate LNU has a product that has market value and is in-demand. Interest from potential clients will only increase after signing on the likes of IMG.
As nice as it would have been for the share price to shoot up on the back of the deal, that just leads to a big sell off of profits and a potential big drop afterwards disappointing those who are holding long-term.
With the share price staying at current levels, and the share raise at $0.003, it builds stability and mitigates the risk of a drop. Think about this, you see the FY23 Financials and Q1 and Q2 FY24 Financials and revenue is significantly increasing with a few more deals added on and costs are remaining stable, getting closer to break even or at least sustainable growth with lower net loss.
The share price will eventually look too enticing to pass up, and potential investors will see it as a bargain buy. Slow and steady, this bad boy will grow and the growth will be realistic. I’m happy with where things are at. Just waiting for the next information on some deals. Would like to think the IMG deal speeds up the other pipeline opportunities.
- Forums
- ASX - By Stock
- LNU
- Ann: Invitation to Linius Virtual Conference
Ann: Invitation to Linius Virtual Conference, page-9
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LNU (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.09M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LNU (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online